Reactivation ofMASPINin non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs)

IRF6 in development and disease: A mediator of quiescence and differentiation

(2011) Caleb M. Bailey et al.   CELL CYCLE

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor

(2010) T J Harvey et al.   GENE THERAPY

Induction of E-Cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition

(2010) Masatoshi Kakihana et al.   Journal of Thoracic Oncology

The Tumor Suppressor Maspin Mediates E2F1-Induced Sensitivity of Cancer Cells to Chemotherapy

(2010) B. Ben Shachar et al.   MOLECULAR CANCER RESEARCH

Maspin Suppresses Survival of Lung Cancer Cells through Modulation of Akt Pathway

(2010) Eunsook Nam et al.   Cancer Research and Treatment

Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery

(2008) Vladimir P. Torchilin   BIOPOLYMERS

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

(2008) Shuomin Zhu et al.   CELL RESEARCH

Expression of Maspin in Non–Small-Cell Lung Cancer: Correlation with Clinical Features

(2008) Iwao Takanami et al.   Clinical Lung Cancer

Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor

(2008) A. S. Beltran et al.   MOLECULAR CANCER THERAPEUTICS

Epigenetic interplay between histone modifications and DNA methylation in gene silencing

(2008) T VAISSIERE et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH